Literature DB >> 24077283

Invading one step at a time: the role of invadopodia in tumor metastasis.

H Paz1, N Pathak2, J Yang3.   

Abstract

The ability to degrade extracellular matrix is critical for tumor cells to invade and metastasize. Recent studies show that tumor cells use specialized actin-based membrane protrusions termed invadopodia to perform matrix degradation. Invadopodia provide an elegant way for tumor cells to precisely couple focal matrix degradation with directional movement. Here we discuss several key components and regulators of invadopodia that have been uniquely implicated in tumor invasion and metastasis. Furthermore, we discuss existing and new therapeutic opportunities to target invadopodia for anti-metastasis treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24077283      PMCID: PMC3969876          DOI: 10.1038/onc.2013.393

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  126 in total

1.  Perspective: The right trials.

Authors:  Patricia S Steeg
Journal:  Nature       Date:  2012-05-30       Impact factor: 49.962

2.  Tks5 recruits AFAP-110, p190RhoGAP, and cortactin for podosome formation.

Authors:  Luca Crimaldi; Sara A Courtneidge; Mario Gimona
Journal:  Exp Cell Res       Date:  2009-06-18       Impact factor: 3.905

3.  Ala657 and conserved active site residues promote fibroblast activation protein endopeptidase activity via distinct mechanisms of transition state stabilization.

Authors:  Sarah A Meadows; Conrad Yap Edosada; Mark Mayeda; Thuy Tran; Clifford Quan; Helga Raab; Christian Wiesmann; Beni B Wolf
Journal:  Biochemistry       Date:  2007-03-24       Impact factor: 3.162

4.  KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer.

Authors:  Muralidharan Anbalagan; Latonya Carrier; Seth Glodowski; David Hangauer; Bin Shan; Brian G Rowan
Journal:  Breast Cancer Res Treat       Date:  2011-04-21       Impact factor: 4.872

5.  Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells.

Authors:  Emma T Bowden; Ena Onikoyi; Rebecca Slack; Akira Myoui; Toshiyuki Yoneda; Kenneth M Yamada; Susette C Mueller
Journal:  Exp Cell Res       Date:  2006-01-25       Impact factor: 3.905

Review 6.  Advances in targeting SRC in the treatment of breast cancer and other solid malignancies.

Authors:  Erica L Mayer; Ian E Krop
Journal:  Clin Cancer Res       Date:  2010-07-15       Impact factor: 12.531

7.  The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices.

Authors:  Giulio Ghersi; Qiang Zhao; Monica Salamone; Yunyun Yeh; Stanley Zucker; Wen-Tien Chen
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

Review 8.  The road to integrative cancer therapies: emergence of a tumor-associated fibroblast protease as a potential therapeutic target in cancer.

Authors:  Ellen Puré
Journal:  Expert Opin Ther Targets       Date:  2009-08       Impact factor: 6.902

9.  Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro.

Authors:  A S Patel; G L Schechter; W J Wasilenko; K D Somers
Journal:  Oncogene       Date:  1998-06-25       Impact factor: 9.867

10.  Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation.

Authors:  Shu Wang; Yuhui Yuan; Lan Liao; Shao-Qing Kuang; Jean Ching-Yi Tien; Bert W O'Malley; Jianming Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-24       Impact factor: 11.205

View more
  80 in total

1.  Sorting nexin 9 negatively regulates invadopodia formation and function in cancer cells.

Authors:  Nawal Bendris; Carrie J S Stearns; Carlos R Reis; Jaime Rodriguez-Canales; Hui Liu; Agnieszka W Witkiewicz; Sandra L Schmid
Journal:  J Cell Sci       Date:  2016-06-08       Impact factor: 5.285

Review 2.  Epithelial-mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?

Authors:  Jente van Staalduinen; David Baker; Peter Ten Dijke; Hans van Dam
Journal:  Oncogene       Date:  2018-07-12       Impact factor: 9.867

3.  Sphingolipids inhibit endosomal recycling of nutrient transporters by inactivating ARF6.

Authors:  Brendan T Finicle; Manuel U Ramirez; Gang Liu; Elizabeth M Selwan; Alison N McCracken; Jingwen Yu; Yoosun Joo; Jannett Nguyen; Kevin Ou; Saurabh Ghosh Roy; Victor D Mendoza; Dania Virginia Corrales; Aimee L Edinger
Journal:  J Cell Sci       Date:  2018-06-25       Impact factor: 5.285

Review 4.  The interplay between the proteolytic, invasive, and adhesive domains of invadopodia and their roles in cancer invasion.

Authors:  Or-Yam Revach; Benjamin Geiger
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

5.  RET isoforms contribute differentially to invasive processes in pancreatic ductal adenocarcinoma.

Authors:  Eric Y Lian; Brandy D Hyndman; Serisha Moodley; Sarah M Maritan; Lois M Mulligan
Journal:  Oncogene       Date:  2020-09-03       Impact factor: 9.867

6.  Prognostic value and molecular correlates of a CT image-based quantitative pleural contact index in early stage NSCLC.

Authors:  Juheon Lee; Yi Cui; Xiaoli Sun; Bailiang Li; Jia Wu; Dengwang Li; Michael F Gensheimer; Billy W Loo; Maximilian Diehn; Ruijiang Li
Journal:  Eur Radiol       Date:  2017-08-07       Impact factor: 5.315

Review 7.  Molecular background of the regional lymph node metastasis of gastric cancer.

Authors:  Tong Zhu; Xueqian Hu; Pinkang Wei; Guangzhi Shan
Journal:  Oncol Lett       Date:  2018-01-16       Impact factor: 2.967

8.  Talin2-mediated traction force drives matrix degradation and cell invasion.

Authors:  Lei Qi; Naser Jafari; Xiang Li; Zaozao Chen; Liqing Li; Vesa P Hytönen; Benjamin T Goult; Chang-Guo Zhan; Cai Huang
Journal:  J Cell Sci       Date:  2016-10-01       Impact factor: 5.285

9.  Macrophages promote matrix protrusive and invasive function of breast cancer cells via MIP-1β dependent upregulation of MYO3A gene in breast cancer cells.

Authors:  Khemraj Singh Baghel; Brij Nath Tewari; Richa Shrivastava; Showkat Ahmad Malik; Mehraj U-Din Lone; Nem Kumar Jain; Chakrapani Tripathi; Ranjana Kumari Kanchan; Sameer Dixit; Kavita Singh; Kalyan Mitra; Mahendra Pal Singh Negi; Mukesh Srivastava; Sanjeev Misra; Madan Lal Brahma Bhatt; Smrati Bhadauria
Journal:  Oncoimmunology       Date:  2016-07-15       Impact factor: 8.110

10.  Gene expression profile of epithelial-mesenchymal transition mediators in papillary thyroid cancer.

Authors:  Ana Lopez-Campistrous; Esther Ekpe Adewuyi; David C Williams; Todd P W McMullen
Journal:  Endocrine       Date:  2020-09-10       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.